VitalNext has finished a pilot study in humans to further document the physiological effects of Promanna. The study took place in Groningen, The Netherlands and focussed on the effects of DNA-damage –and the inhibiting effects thereof by Promanna- on parameters and biomarkers are relevant to healthy ageing. The study was performed in healthy volunteers age 60 and over. Currently, analyses of the data are performed and will be published on this website soon. We expect to initiate additional studies at various international locations on the effects of Promanna in healthy ageing in the future.
People interested in participation in a future VitalNext study are requested to send a mail to email@example.com